DRG Market Assessment reports

Venous thromboembolism (VTE) is the obstruction of a vein caused by a thrombus. It consists of deep vein thrombosis (DVT) and pulmonary embolism (PE), depending on the location of the obstruction…

Although chemotherapy has traditionally been the cornerstone of ovarian cancer treatment, angiogenesis and PARP inhibitors have revolutionized the treatment landscape, impacting prescribing…

Regional Forecast is an add on offering from Clarivate’s Company & Drugs (C&D) that renders extended coverage of existing C&D proprietary data. With increasing demand to analyze the data in much…

Clarivate Epidemiology’s coverage of retinal vein occlusion (RVO) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RVO for…

Clarivate Epidemiology’s coverage of osteopenia (OPE) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key OPE patient populations, covering 171 countries and more than 99% of…

Clarivate’s Epidemiology’s coverage of osteopenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of osteopenia for each…

Clarivate Epidemiology’s coverage of osteopenia (OPE) comprises epidemiological estimates of key patient populations in seven emerging pharmaceutical markets. We report the prevalence of OPE for…

Gout is a painful, systemic inflammatory condition caused by elevated serum uric acid (sUA) and characterized by intermittent acute flares. Treatment of acute gout flares typically involves NSAIDs…

The renal cell carcinoma (RCC) therapy market is rapidly evolving and experiencing substantial growth, largely driven by the increasing uptake of immune checkpoint inhibitors. Combination regimens…

Clarivate Epidemiology’s coverage of marginal zone lymphoma (MZL) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

Graft versus host disease (GVHD) is a potentially life-threatening complication of allogenic hematopoietic stem cell transplantation (HSCT). Steroids have been the first-line therapy for the…